Abstract

These investigators found that elevated vancomycin MICs were associated with increased mortality in patients with MRSA infections, a result mostly driven by outcomes of bloodstream infections (BSIs). In contrast, excess mortality in association with elevated MICs was not seen in non-BSI MRSA infections. Among patients with MRSA BSI, although an Etest MIC $2 lg/mL was associated with increased mortality, an Etest MIC of 1.5 lg/mL was not. Throughout the analysis of van Hal

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call